Hepatitis C and intravenous immunoglobulin:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Belle Mead, NJ
Excerpta Medica
1996
|
| Schriftenreihe: | Clinical therapeutics
18,Suppl.B |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-Suppl. |
| Beschreibung: | 139 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011540639 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 970919s1996 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)37465845 | ||
| 035 | |a (DE-599)BVBBV011540639 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Hepatitis C and intravenous immunoglobulin |c Raif S. Geha, ed. |
| 264 | 1 | |a Belle Mead, NJ |b Excerpta Medica |c 1996 | |
| 300 | |a 139 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Clinical therapeutics |v 18,Suppl.B | |
| 500 | |a Einzelaufnahme eines Zeitschr.-Suppl. | ||
| 650 | 4 | |a Hepacivirus |v Congresses | |
| 650 | 4 | |a Hepatitis C virus |v Congresses | |
| 650 | 4 | |a Hepatitis C |v Congresses | |
| 650 | 4 | |a Hepatitis C |x transmission |v Congresses | |
| 650 | 4 | |a Immunoglobulins |x Therapeutic use |x Side effects |v Congresses | |
| 650 | 4 | |a Immunoglobulins, Intravenous |v Congresses | |
| 650 | 4 | |a Plasma products |x Microbiology |v Congresses | |
| 650 | 0 | 7 | |a Immunglobuline |0 (DE-588)4026626-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hepatitis C |0 (DE-588)4262007-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Intravenöse Applikation |0 (DE-588)4525889-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1995 |z Orlando Fla. |2 gnd-content | |
| 689 | 0 | 0 | |a Immunglobuline |0 (DE-588)4026626-6 |D s |
| 689 | 0 | 1 | |a Intravenöse Applikation |0 (DE-588)4525889-2 |D s |
| 689 | 0 | 2 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Immunglobuline |0 (DE-588)4026626-6 |D s |
| 689 | 1 | 1 | |a Intravenöse Applikation |0 (DE-588)4525889-2 |D s |
| 689 | 1 | 2 | |a Hepatitis C |0 (DE-588)4262007-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Geha, Raif S. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007768563 | ||
Datensatz im Suchindex
| _version_ | 1804126063491547136 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011540639 |
| ctrlnum | (OCoLC)37465845 (DE-599)BVBBV011540639 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01901nam a2200505 cb4500</leader><controlfield tag="001">BV011540639</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970919s1996 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)37465845</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011540639</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hepatitis C and intravenous immunoglobulin</subfield><subfield code="c">Raif S. Geha, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Belle Mead, NJ</subfield><subfield code="b">Excerpta Medica</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">139 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Clinical therapeutics</subfield><subfield code="v">18,Suppl.B</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-Suppl.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepacivirus</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis C virus</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis C</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis C</subfield><subfield code="x">transmission</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunoglobulins</subfield><subfield code="x">Therapeutic use</subfield><subfield code="x">Side effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunoglobulins, Intravenous</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Plasma products</subfield><subfield code="x">Microbiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunglobuline</subfield><subfield code="0">(DE-588)4026626-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hepatitis C</subfield><subfield code="0">(DE-588)4262007-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Intravenöse Applikation</subfield><subfield code="0">(DE-588)4525889-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1995</subfield><subfield code="z">Orlando Fla.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Immunglobuline</subfield><subfield code="0">(DE-588)4026626-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Intravenöse Applikation</subfield><subfield code="0">(DE-588)4525889-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Immunglobuline</subfield><subfield code="0">(DE-588)4026626-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Intravenöse Applikation</subfield><subfield code="0">(DE-588)4525889-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Hepatitis C</subfield><subfield code="0">(DE-588)4262007-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geha, Raif S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007768563</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1995 Orlando Fla. gnd-content |
| genre_facet | Konferenzschrift 1995 Orlando Fla. |
| id | DE-604.BV011540639 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:11:30Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007768563 |
| oclc_num | 37465845 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 139 S. graph. Darst. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Excerpta Medica |
| record_format | marc |
| series2 | Clinical therapeutics |
| spelling | Hepatitis C and intravenous immunoglobulin Raif S. Geha, ed. Belle Mead, NJ Excerpta Medica 1996 139 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Clinical therapeutics 18,Suppl.B Einzelaufnahme eines Zeitschr.-Suppl. Hepacivirus Congresses Hepatitis C virus Congresses Hepatitis C Congresses Hepatitis C transmission Congresses Immunoglobulins Therapeutic use Side effects Congresses Immunoglobulins, Intravenous Congresses Plasma products Microbiology Congresses Immunglobuline (DE-588)4026626-6 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Hepatitis C (DE-588)4262007-7 gnd rswk-swf Intravenöse Applikation (DE-588)4525889-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1995 Orlando Fla. gnd-content Immunglobuline (DE-588)4026626-6 s Intravenöse Applikation (DE-588)4525889-2 s Arzneimittelnebenwirkung (DE-588)4003134-2 s DE-604 Hepatitis C (DE-588)4262007-7 s Geha, Raif S. Sonstige oth |
| spellingShingle | Hepatitis C and intravenous immunoglobulin Hepacivirus Congresses Hepatitis C virus Congresses Hepatitis C Congresses Hepatitis C transmission Congresses Immunoglobulins Therapeutic use Side effects Congresses Immunoglobulins, Intravenous Congresses Plasma products Microbiology Congresses Immunglobuline (DE-588)4026626-6 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Hepatitis C (DE-588)4262007-7 gnd Intravenöse Applikation (DE-588)4525889-2 gnd |
| subject_GND | (DE-588)4026626-6 (DE-588)4003134-2 (DE-588)4262007-7 (DE-588)4525889-2 (DE-588)1071861417 |
| title | Hepatitis C and intravenous immunoglobulin |
| title_auth | Hepatitis C and intravenous immunoglobulin |
| title_exact_search | Hepatitis C and intravenous immunoglobulin |
| title_full | Hepatitis C and intravenous immunoglobulin Raif S. Geha, ed. |
| title_fullStr | Hepatitis C and intravenous immunoglobulin Raif S. Geha, ed. |
| title_full_unstemmed | Hepatitis C and intravenous immunoglobulin Raif S. Geha, ed. |
| title_short | Hepatitis C and intravenous immunoglobulin |
| title_sort | hepatitis c and intravenous immunoglobulin |
| topic | Hepacivirus Congresses Hepatitis C virus Congresses Hepatitis C Congresses Hepatitis C transmission Congresses Immunoglobulins Therapeutic use Side effects Congresses Immunoglobulins, Intravenous Congresses Plasma products Microbiology Congresses Immunglobuline (DE-588)4026626-6 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Hepatitis C (DE-588)4262007-7 gnd Intravenöse Applikation (DE-588)4525889-2 gnd |
| topic_facet | Hepacivirus Congresses Hepatitis C virus Congresses Hepatitis C Congresses Hepatitis C transmission Congresses Immunoglobulins Therapeutic use Side effects Congresses Immunoglobulins, Intravenous Congresses Plasma products Microbiology Congresses Immunglobuline Arzneimittelnebenwirkung Hepatitis C Intravenöse Applikation Konferenzschrift 1995 Orlando Fla. |
| work_keys_str_mv | AT geharaifs hepatitiscandintravenousimmunoglobulin |